Dr. Colm Henry:

The primary lessons we learned were through the very successful campaign during the pandemic when we learned about more effective ways, primarily through the GP network, of administering the vaccine. Drawing on the past couple of years, if there was one disappointing aspect of the flu vaccine roll-out, it was the uptake of the live, attenuated influenza vaccine, LAIV, among children. We are reviewing the mode of administration of that now, which is primarily through GPs, to see if we can engage our school immunisation teams where there is a higher uptake of the established vaccination regimes for children, to see if we can increase the current uptake of 13 or 14%, which is too low, to a higher level that has been achieved in other countries.